BIOFIL CHEMICALS & PHARMACEUTICALS
|
|
BOM : 524396     NSE : BIOFILCHEM     | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : NA |
Feb 18,2025 |
Price(EOD): ₹ 47.98
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 78.21 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
BIOFIL CHEMICALS & PHARMACEUTICALS | -7.8% | -15.3% | -28.2% |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -3.4% | 13.4% |
CIPLA | 2.2% | 3.9% | 2.3% |
DR REDDYS LABORATORIES | -1.5% | -7% | -5% |
ZYDUS LIFESCIENCES | -2.3% | -7.4% | 3.7% |
DIVIS LABORATORIES | -2.2% | 0.3% | 58.8% |
MANKIND PHARMA | -1.4% | -6.9% | 5.9% |
TORRENT PHARMACEUTICALS | -0.6% | -3.5% | 16.5% |
LUPIN | -0.6% | -4.3% | 25% |
FUNDAMENTAL ANALYSIS OF BIOFIL CHEMICALS & PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF BIOFIL CHEMICALS & PHARMACEUTICALS
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
129.06
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 0.61 Cr
[Latest Qtr - Dec2024 - Standalone Results ] 4.29
P/B Calculated based on Book Value of Rs 18.20 Cr
[Latest Year - Mar2024 - Standalone Results ] 1.94
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
34% -20% -20% |
SHARE PRICE MOMENTUM OF BIOFIL CHEMICALS & PHARMACEUTICALS
BIOFIL CHEMICALS & PHARMACEUTICALS vs SENSEX
DEBT OF BIOFIL CHEMICALS & PHARMACEUTICALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.02 0.03 0.03 0.03 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF BIOFIL CHEMICALS & PHARMACEUTICALS
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF BIOFIL CHEMICALS & PHARMACEUTICALS
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
488.27% 147.58% 590.63% 583.33% |
182.1% 58.25% 93.86% 74.47% |
QtrlyTrend |
8 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
BIOFIL CHEMICALS & PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about BIOFIL CHEMICALS & PHARMACEUTICALS
Is BIOFIL CHEMICALS & PHARMACEUTICALS good for long term investment?
As on Feb 18,2025, the Fundamentals of BIOFIL CHEMICALS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of BIOFIL CHEMICALS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is BIOFIL CHEMICALS & PHARMACEUTICALS UnderValued or OverValued?
As on Feb 18,2025, BIOFIL CHEMICALS & PHARMACEUTICALS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of BIOFIL CHEMICALS & PHARMACEUTICALS ?
As on Feb 18,2025, the Intrinsic Value of BIOFIL CHEMICALS & PHARMACEUTICALS is Rs. 60.15 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 35.88
Fair Value [Median EV / Sales Model] : Rs. 60.15
Fair Value [Median Price / Sales Model] : Rs. 60.22
Estimated Median Fair Value of BIOFIL CHEMICALS & PHARMACEUTICALS : Rs. 60.15
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.